These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3733986)

  • 1. Simultaneous determination of serum uremic toxins, cations and anions and urea determination by post-column colorimetry using immobilized enzyme.
    Shintani H
    J Chromatogr; 1986 May; 378(1):95-108. PubMed ID: 3733986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of serum cations, anions and uremic toxins by ion chromatography using an immobilized enzyme.
    Shintani H; Ube S
    J Chromatogr; 1985 Nov; 344():145-56. PubMed ID: 4086536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of urea in serum based on the combination of an enzymatic reaction with immobilized urease and ion chromatographic analysis.
    Miyauchi T; Miyachi Y; Takahashi M; Ishikawa N; Mori H
    Anal Sci; 2010; 26(8):847-51. PubMed ID: 20702937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion-pair high-performance liquid chromatography profiling of a uremic toxin fraction.
    Gallice P; Monti JP; Le Gall JM; Crevat A; Murisasco A
    J Chromatogr; 1987 Nov; 422():263-6. PubMed ID: 3437013
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous quantitative analysis of uremic toxins by LC-MS/MS with a reversed-phase/cation-exchange/anion-exchange tri-modal mixed-mode column.
    Kanemitsu Y; Asaji K; Matsumoto Y; Tsukamoto H; Saigusa D; Mukawa C; Tachikawa T; Abe T; Tomioka Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():1-8. PubMed ID: 29024911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and identification of canine plasma components suspected as uremic toxins.
    Kawamura M; Ohashi F; Nagata Y; Takai N; Motoie H; Nishimura R; Sasaki N; Takeuchi A
    J Vet Med Sci; 1993 Apr; 55(2):265-70. PubMed ID: 8513007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic toxins and the elusive middle molecules.
    Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
    Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of hemodialysis on endogenous middle molecules in uremic patients.
    Asaba H; Fürst P; Oulés R; Yahiel V; Zimmerman L; Bergström J
    Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance.
    Gallice P; Monti JP; Crevat A; Durand C; Murisasco A
    Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of common inorganic anions and cations by non-suppressed ion chromatography with column switching.
    Amin M; Lim LW; Takeuchi T
    J Chromatogr A; 2008 Feb; 1182(2):169-75. PubMed ID: 18221746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A; Myśliwiec M; Soszka J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tunable separation of anions and cations by column switching in ion chromatography.
    Amin M; Lim LW; Takeuchi T
    Talanta; 2007 Mar; 71(4):1470-5. PubMed ID: 19071477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical study for separation of middle molecules.
    Saito A; Kanazawa I; Chung TG; Maeda K
    Artif Organs; 1981; 4 Suppl():13-6. PubMed ID: 6975092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New analyser for the determination of urinary vanillylmandelic acid, homovanillic acid and creatinine.
    Kawaguchi S; Hirachi N; Fukamachi M
    J Chromatogr; 1991 Jun; 567(1):11-9. PubMed ID: 1918237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical analytic approaches to the definition of uremic toxins.
    Furst P; Bergstrom J; Gordon A; Zimmermann L
    Ateneo Parmense Acta Biomed; 1975; 46(5):307-16. PubMed ID: 1232992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of pharmaceutical products using simultaneous mixed-mode (ion-exchange/reversed-phase) and hydrophilic interaction liquid chromatography.
    Kazarian AA; Nesterenko PN; Soisungnoen P; Burakham R; Srijaranai S; Paull B
    J Sep Sci; 2014 Aug; 37(16):2138-44. PubMed ID: 24890905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uremic middle molecules exist and are biologically active.
    Bergström J; Fürst P; Zimmerman L
    Clin Nephrol; 1979 May; 11(5):229-38. PubMed ID: 455821
    [No Abstract]   [Full Text] [Related]  

  • 18. Ascorbic acid derivatives in two different fractions of uremic toxins.
    Gallice PM; Monti JP; Braguer DL; Baz M; Elsen RE; Berland YF; Crevat AD
    Int J Artif Organs; 1991 Dec; 14(12):754-8. PubMed ID: 1783448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippuric acid as a marker.
    Vanholder R; Schoots A; Cramers C; De Smet R; Van Landschoot N; Wizemann V; Botella J; Ringoir S
    Adv Exp Med Biol; 1987; 223():59-67. PubMed ID: 3447451
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous Analysis of Monovalent Anions and Cations with a Sub-Microliter Dead-Volume Flow-Through Potentiometric Detector for Ion Chromatography.
    Dumanli R; Attar A; Erci V; Isildak I
    J Chromatogr Sci; 2016 Apr; 54(4):598-603. PubMed ID: 26786906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.